Australia markets closed

Telix Pharmaceuticals Limited (TLX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
14.91+0.03 (+0.20%)
At close: 04:10PM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 4.93B
Enterprise value 4.82B
Trailing P/E 926.09
Forward P/E 60.98
PEG ratio (5-yr expected) N/A
Price/sales (ttm)9.58
Price/book (mrq)33.09
Enterprise value/revenue 9.71
Enterprise value/EBITDA 209.93

Trading information

Stock price history

Beta (5Y monthly) 2.35
52-week change 346.90%
S&P500 52-week change 321.08%
52-week high 315.01
52-week low 38.20
50-day moving average 312.34
200-day moving average 310.87

Share statistics

Avg vol (3-month) 31.19M
Avg vol (10-day) 31.39M
Shares outstanding 5330.45M
Implied shares outstanding 6330.45M
Float 8254.41M
% held by insiders 125.15%
% held by institutions 111.79%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 1.04%
Operating margin (ttm)7.23%

Management effectiveness

Return on assets (ttm)9.92%
Return on equity (ttm)4.55%

Income statement

Revenue (ttm)502.55M
Revenue per share (ttm)1.57
Quarterly revenue growth (yoy)107.10%
Gross profit (ttm)N/A
EBITDA 57.17M
Net income avi to common (ttm)5.21M
Diluted EPS (ttm)0.02
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)123.24M
Total cash per share (mrq)0.38
Total debt (mrq)17.45M
Total debt/equity (mrq)11.72%
Current ratio (mrq)1.43
Book value per share (mrq)0.46

Cash flow statement

Operating cash flow (ttm)23.88M
Levered free cash flow (ttm)62.9M